High plasma C-terminal FGF-23 levels predict poor outcomes in patients with chronic kidney disease superimposed with acute kidney injury.
Yu-Hsing ChangChe-Hsiung WuNai-Kuan ChouLi-Jung TsengI-Ping HuangChih-Hsien WangVin-Cent WuTzong-Shinn ChuPublished in: Therapeutic advances in chronic disease (2020)
In patients with ACKD, plasma cFGF-23 levels are an independent risk factor to forecast 90-day mortality and 90-day progression to KFRT. In combination with the clinical risk score, plasma cFGF-23 levels could substantially improve mortality risk prediction.